News & Updates

Adolescents with juvenile idiopathic arthritis (JIA) remain vulnerable to symptoms of depression and anxiety, particularly panic, according to a study, noting the ongoing need for mental health screening protocols and services in this population.

Use of psychedelic drugs appears to have some benefits in reducing anxiety and depressive symptoms among patients with cancer or other life-threatening diseases, reports a study.

People with social anxiety disorder (SAD) may benefit from gaze-contingent music reward therapy (GC-MRT), an eye-tracking-based attention bias modification treatment, which has been shown to reduce SAD symptoms in a recent study.

Genetic predisposition to major depressive disorder has the potential to increase the risk of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), peptic ulcer disease, and nonalcoholic fatty liver disease (NAFLD), according to the results of a Mendelian randomization study.

COVID-19 vaccine boosters provide protection against Omicron infection and related hospitalization among people with substance use disorder, researchers from the University of Hong Kong have reported.

Modulation of gut microbiome using the SIM01 synbiotic formula significantly improves neuropsychiatric and gastrointestinal (GI) symptoms of long COVID, according to results of the randomized, triple-blind, placebo-controlled RECOVERY study conducted by researchers from the Chinese University of Hong Kong (CUHK).